Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
<!-- Name:DistributionId Value:8744031 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Biosciences
Pardes Biosciences to Present at SVB Securities Global Biopharma Conference
<!-- Name:DistributionId Value:8735031 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Junshi Biosciences Announces Toripalimab as Perioperative Treatment for Operable…
SHANGHAI, China, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical…
Junshi Biosciences Announces Acceptance of NDA for VV116 in China
SHANGHAI, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical…
Human Microbiome Market Report (2022 to 2030) – Obiome, 4D Pharma, Vedanta…
Pune, Jan. 10, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Human Microbiome Market by Product (Probiotics, Prebiotics, Symbiotics, Medical Food, Drugs and…
Solid Biosciences Reports Inducement Grant to Chief Financial Officer and Treasurer
CHARLESTOWN, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases,…
Neurological Biomarkers Market Report (2022 to 2030) – Abbott Laboratories, Qiagen,…
Pune, Jan. 09, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Neurological Biomarkers Market by Type (Genomic, Metabolomic, Proteomic, Imaging), by…
Prometheus Biosciences to Present at the 41st Annual J.P. Morgan Healthcare…
SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the…
Junshi Biosciences and Coherus Share Update on the FDA Review of the Biologics…
- FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA - - Junshi Biosciences and Coherus are actively engaged in ongoing…
Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 2…
REDWOOD CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (“Imago” or the “Company”) (Nasdaq: IMGO), a clinical-stage biopharmaceutical company discovering and…